These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 26834043)
21. SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas. Küsters-Vandevelde HV; Creytens D; van Engen-van Grunsven AC; Jeunink M; Winnepenninckx V; Groenen PJ; Küsters B; Wesseling P; Blokx WA; Prinsen CF Acta Neuropathol Commun; 2016 Jan; 4():5. PubMed ID: 26769193 [TBL] [Abstract][Full Text] [Related]
22. BAP1 mutations in high-grade meningioma: implications for patient care. Shankar GM; Santagata S Neuro Oncol; 2017 Oct; 19(11):1447-1456. PubMed ID: 28482042 [TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. Gerami P; Pouryazdanparast P; Vemula S; Bastian BC Am J Dermatopathol; 2010 May; 32(3):301-305. PubMed ID: 20110797 [TBL] [Abstract][Full Text] [Related]
26. Recurrent intracranial melanocytoma associated with a nevus of Ota. Rutten I; Bolle S; Kaschten B; Stevenaert A; Deneufbourg JM; Deprez M Acta Neurochir (Wien); 2005 Mar; 147(3):313-5; discussion 315. PubMed ID: 15618991 [No Abstract] [Full Text] [Related]
27. Unpigmented nodule with loss of BAP1 expression in a medium-sized congenital nevus. Rocas D; Castillo C; Lamarca S; Gallateau-Salle F; Paindavoine S; Pissaloux D; De La Fouchardiere A Eur J Dermatol; 2015 Apr; 25(2):201-2. PubMed ID: 25652719 [No Abstract] [Full Text] [Related]
28. [Meningeal melanocytoma with nevus fuscoceruleus ophthalmomaxillaris: report of a case]. WU C; WANG H; SHI QL; MA HH; LU ZF Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):194-5. PubMed ID: 21575395 [No Abstract] [Full Text] [Related]
29. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system. van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134 [TBL] [Abstract][Full Text] [Related]
30. Intracranial intermediate-grade meningeal melanocytoma with increased cellular proliferative index: an illustrative case associated with a nevus of Ota. Navas M; Pascual JM; Fraga J; Pedrosa M; Shakur S; Carrasco R; Martínez P; Manzanares R; de Sola RG J Neurooncol; 2009 Oct; 95(1):105-115. PubMed ID: 19449182 [TBL] [Abstract][Full Text] [Related]
31. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma. Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891 [TBL] [Abstract][Full Text] [Related]
32. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183 [TBL] [Abstract][Full Text] [Related]
33. BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers. Kuznetsov JN; Aguero TH; Owens DA; Kurtenbach S; Field MG; Durante MA; Rodriguez DA; King ML; Harbour JW Sci Adv; 2019 Sep; 5(9):eaax1738. PubMed ID: 31555735 [TBL] [Abstract][Full Text] [Related]
35. BAP1-deficient meningioma presenting with trabecular architecture and cytokeratin expression: a report of two cases and review of the literature. Landry AP; Wang JZ; Nassiri F; Patil V; Gao A; Zadeh G J Clin Pathol; 2023 May; 76(5):315-319. PubMed ID: 34907091 [TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874 [TBL] [Abstract][Full Text] [Related]
37. Concerns About Presence of a Wild-Type BAP1 Allele in Absence of Nuclear Protein Expression. Napolitano A; Carbone M JAMA Dermatol; 2015 Nov; 151(11):1265-6. PubMed ID: 26559347 [No Abstract] [Full Text] [Related]
38. Concerns About Presence of a Wild-Type BAP1 Allele in Absence of Nuclear Protein Expression-Reply. Gerami P; Tsao H JAMA Dermatol; 2015 Nov; 151(11):1266. PubMed ID: 26559348 [No Abstract] [Full Text] [Related]
39. Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma. Sargen MR; Cloutier JM; Sarin KY; Rieger KE; Chu P; Swetter SM; Novoa RA Pigment Cell Melanoma Res; 2019 May; 32(3):474-478. PubMed ID: 30672662 [No Abstract] [Full Text] [Related]
40. Melanoma arising in a nevus of Ito: novel genetic mutations and a review of the literature on cutaneous malignant transformation of dermal melanocytosis. Tse JY; Walls BE; Pomerantz H; Yoon CH; Buchbinder EI; Werchniak AE; Dong F; Lian CG; Granter SR J Cutan Pathol; 2016 Jan; 43(1):57-63. PubMed ID: 26260725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]